In total, 46% (19 out of 41) of all ovarian serous adenocarcinomas were positive for FRAT1 expression, followed by four out of 11 clear cell, four out of five endometrioid and one out of three mucinous adenocarcinomas (Table 1). The gene discussed is FRAT1; the disease is mucinous adenocarcinoma.